Beleave Inc BLEVF

Beleave Inc is a vertically integrated Canadian cannabis company. It operates streamlined facilities throughout Canada to cultivate high quality cannabis flower, oil and extracts with funded capacity more than 150,000 kilograms per year. Fully licensed to cultivate and sell medical and recreational cannabis, it is leading the way through research partnerships with universities to bridge the gap between science and tradition and to develop pharma-grade extracts and derivatives. The company is currently developing new product lines as the recreational market is expected to allow for food and beverage-based cannabis products.

GREY:BLEVF - Post by User

Beleave Inc

Bullboard Posts

Comment by jb24on Aug 12, 2019 11:27pm

188 Views

Post# 30020577

RE:SEDI Insider filing 🤔🤔🤔

Message received!!!!!!!!!!!!!!!!!!!!!

Thefinals23 wrote:

Date Issuer Insider Transaction Amount New Total

Recent filings

2019-08-1216:29

2019-08-02 $BE Panagiotakopoulos, Vasilios
4 - Director of Issuer

Common Shares
16 - Acquisition or disposition under a prospectus exemption $499,999.99
+7,142,857vol
$0.07 each

2019-08-1213:27

2019-08-02 $BE Panagiotakopoulos, Vasilios
4 - Director of Issuer

Common Shares
16 - Acquisition or disposition under a prospectus exemption $499,999.99
+7,142,857vol
$0.07 each

2019-08-1213:27

2019-08-02 $BE Panagiotakopoulos, Vasilios
4 - Director of Issuer

Common Shares
16 - Acquisition or disposition under a prospectus exemption $499,999.99
+7,142,857vol
$0.07 each 9,175,857

Date	Issuer	Insider	Transaction	Amount	New Total
Recent filings
2019-08-1216:29 2019-08-02	$BE	Panagiotakopoulos, Vasilios 4 - Director of Issuer	Common Shares 16 - Acquisition or disposition under a prospectus exemption	$499,999.99 +7,142,857vol $0.07 each
2019-08-1213:27 2019-08-02	$BE	Panagiotakopoulos, Vasilios 4 - Director of Issuer	Common Shares 16 - Acquisition or disposition under a prospectus exemption	$499,999.99 +7,142,857vol $0.07 each
2019-08-1213:27 2019-08-02	$BE	Panagiotakopoulos, Vasilios 4 - Director of Issuer	Common Shares 16 - Acquisition or disposition under a prospectus exemption	$499,999.99 +7,142,857vol $0.07 each	9,175,857